Myleran, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Myleran

Busulfan

Prescription required

$585.00

2mg · 100 tablets · 3 months supply

BrandBranded medicine· By GSK

$195.00 per month

How long a supply?

3 months$195.00 a month
6 months$195.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$2340a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

FDA boxed warning

WARNING

MYLERAN is a potent drug. It should not be used unless a diagnosis of chronic myelogenous leukemia has been adequately established and the responsible physician is knowledgeable in assessing response to chemotherapy.

MYLERAN can induce severe bone marrow hypoplasia. Reduce or discontinue the dosage immediately at the first sign of any unusual depression of bone marrow function as reflected by an abnormal decrease in any of the formed elements of the blood. A bone marrow examination should be performed if the bone marrow status is uncertain.

Read this with the rest of the clinical information

About Myleran

Overview

Myleran is a prescription tablet containing busulfan. It is used for palliative treatment of chronic myelogenous leukemia, meaning treatment aimed at relief rather than cure. Busulfan is an alkylating agent, which works through a chemical process called alkylation.

What it treats

Palliative treatment of chronic myelogenous leukemia (also called myeloid, myelocytic or granulocytic leukemia).

Safety information

Side effects

Report suspected side effects to Waylis Therapeutics LLC at 1-888-514-4727 or to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

FDA boxed warning

WARNING

MYLERAN is a potent drug. It should not be used unless a diagnosis of chronic myelogenous leukemia has been adequately established and the responsible physician is knowledgeable in assessing response to chemotherapy.

MYLERAN can induce severe bone marrow hypoplasia. Reduce or discontinue the dosage immediately at the first sign of any unusual depression of bone marrow function as reflected by an abnormal decrease in any of the formed elements of the blood. A bone marrow examination should be performed if the bone marrow status is uncertain.

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

When to call your doctor

- Contact your doctor immediately if blood tests show an unusual drop in your blood cell counts. This may mean your bone marrow is not making enough blood cells.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not take Myleran if a diagnosis of chronic myelogenous leukemia has not been firmly established, or if you have previously had an allergic reaction to busulfan or any other ingredient in Myleran.

Interactions

Myleran (busulfan) may interact with: • Other medicines that suppress bone marrow: combined use may further reduce blood cell production. • Thioguanine: long-term continuous use with busulfan has been associated with liver problems, increased pressure in the vein supplying the liver, and enlarged veins in the oesophagus. • Other cytotoxic medicines: harmful effects on the lungs may add to those caused by busulfan. • Itraconazole: systemic treatment may slow the removal of busulfan from the body in patients receiving high-dose Myleran. Monitoring for signs of busulfan toxicity is needed when these medicines are used together. Tell your doctor if you take any of these medicines.

Using Myleran

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label MYLERAN (BUSULFAN) TABLET, FILM COATED [WAYLIS THERAPEUTICS LLC] (DailyMed, retrieved 19 September 2026).

Patient information and references

Official and supporting information to read alongside advice from your prescriber or pharmacist.

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines